| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.087 | 0.05 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |